Week of June 12, 2019
Diabetics Exposed to Common Household Chemicals Have Lower Heart Disease Rates, Study Finds
Science Daily: “The Centers for Disease Control and Prevention deemed exposure to perfluoroalkyl substances — a class of chemicals used in cookware, cleaning products and paint — a public health concern. But new research explores how exposure to PFAS may be linked to lower heart disease rates in diabetic adults.” Click here for full story.
D2d: Vitamin D Doesn’t Stop Diabetes in Those With Prediabetes
Medscape: “Vitamin D3 supplementation in people at high risk of developing diabetes but who did not have vitamin D insufficiency does not reduce the chances of developing the disease compared with placebo, the new results of a randomized, placebo-controlled trial show.” Click here for full story.
IDegLira Offers Durable Benefit in Uncontrolled T2D
MedPage Today: “Insulin degludec plus liraglutide (IDegLira) was more durable than insulin glargine (IGlar U100) in maintaining glycemic control in patients with uncontrolled type 2 diabetes on oral antidiabetic drugs, a researcher reported here.” Click here for full story.
Pregnant Teens With Diabetes at “Exceptional Risk” for Complications
Healio: “Having diabetes has long been known to increase the risk of certain pregnancy-related complications — risks that can often be minimized by optimizing blood glucose control. But according to a new study, one group is particularly hard-hit by complications during pregnancy and childbirth: teenagers.” Click here for full story.
Liraglutide Preserves Beta-Cell Function in New Type 1 Diabetes
Medscape: “The glucagon-like peptide-1 (GLP-1) agonist liraglutide (Victoza, Novo Nordisk) taken every day preserved postprandial insulin secretion for 1 year after type 1 diabetes diagnosis in patients in the NewLira trial, while the effects disappeared 6 weeks after treatment stopped.” Click here for full story.
B Vitamins May Lower Type 2 Diabetes Risk, Intake Order May Impact Onset
Healio: “Researchers linked consumption of vitamins B2 and B6 to a lower risk for type 2 diabetes, according to a study presented at Nutrition 2019. A second study, also presented at Nutrition 2019, indicated that the order in which food is eaten may influence the onset of diabetes.” Click here for full story.
Lower Insulin Demand Associated With Gluten-Free Diet in Recent-Onset T1D
Endocrinology Advisor: “A gluten-free diet was associated with lower insulin demand and lower glycated hemoglobin (HbA1c) in newly diagnosed nonceliac pediatric patients with type 1 diabetes (T1D), according to study results presented at the American Diabetes Association 79th Scientific Sessions, held June 7 to 11, 2019, in San Francisco, California.” Click here for full story.
Terrifying Complications in 20 Year Olds With Type 2 Diabetes
Medscape: “Young people who were diagnosed with type 2 diabetes in their early teens had an ‘alarming’ high rate of diabetes-associated complications by the time they were in their mid-20s, according to new research.” Click here for full story.
Undetected Diabetes Linked to Heart Attack and Gum Disease
EurekAlert: “People with undetected glucose disorders run a higher risk of both myocardial infarction and periodontitis, according to a study published in the journal Diabetes Care by researchers at Karolinska Institutet in Sweden. The results demonstrate the need of greater collaboration between dentistry and healthcare, say the researchers, and possibly of screening for diabetes at dental clinics.” Click here for full story.
Week of June 5, 2019
Diabetes Funding In Danger, Unless Congress Acts
WRBL.com: “The U.S. Centers for Disease Control and Prevention says Diabetes is the 7th leading cause of death in the United States and affects nearly 10 percent of the US population. The federal government supports important Diabetes Research at the National Institutes of Health—to the tune of $150-million a year. That funding will dry up unless Congress acts soon.” Click here for full story.
Depression Sufferers at Risk of Multiple Chronic Diseases
Science Daily: “Women who experience symptoms of depression are at risk of developing multiple chronic diseases, research led by The University of Queensland has found.” Click here for full story.
Mediterranean Diet, Improved Glycemic Control Provide Combined Cognitive Benefits
Healio: “Adults with type 2 diabetes may be able to improvements their cognitive abilities by incorporating a Mediterranean diet into their regular disease management regimens, according to findings published in Diabetes Care.” Click here for full story.
Type 2 Diabetes: High-Intensity Exercise May Restore Heart Function
Medical News Today: “Type 2 diabetes can sometimes result in a loss of heart function. However, the results of a new study suggest this function may be recovered through high-intensity exercise.” Click here for full story.
Human Insulin May Be a Lower-Cost Option for Some People With Diabetes
Harvard Health Publishing: “Of the estimated 23 million people in the US who have been diagnosed with diabetes, more than 30% take daily insulin injections to control their blood sugar (glucose) levels. Chances are good that someone you know has been startled by the high cost of this medication.” Click here for full story.
CDC: Fewer Adults Getting Diagnosed With Diabetes
WebMD: “It’s unclear why new cases of diabetes among U.S. adults are decreasing while obesity rates continue to climb, experts say. The number of new diabetes cases fell from 1.7 million in 2009 to 1.3 million in 2017, according to federal data released Tuesday, the Associated Press reported.” Click here for full story.
T1D Exchange Launches Online Registry to Drive Type 1 Diabetes Research
Yahoo Finance: “T1D Exchange today announced the official launch of the T1D Exchange Registry, an online longitudinal database of people living with type 1 diabetes (T1D). This pioneering effort provides a mobile-friendly platform for people throughout the U.S. to participate online and share information about their T1D in order to help researchers develop more targeted and effective approaches to treating and living with the disease.” Click here for full story.
X Cell in the Immune System Identified Which Could Be Linked to Type 1 Diabetes
Diabetes.co.uk: “Scientists have discovered a rogue immune cell coined the X cell which may be behind the development of type 1 diabetes. U.S. scientists from Johns Hopkins Medicine and IBM Research say further studies are needed to confirm the discovery, but claim they have “strong evidence” it could be a driver for type 1 diabetes.” Click here for full story.
FDA Approves New Treatment for Diabetic Condition That Can Lead to Blindness
Healthline: “A new treatment option — Eylea, from Regeneron Pharmaceuticals — has just been approved by the Food and Drug Administration (FDA) to treat all stages of diabetic retinopathy.” Click here for full story.
Week of May 29, 2019
High-Intensity Exercise May Restore Heart Function in People With Type 2 Diabetes
Science Daily: “University of Otago researchers have discovered that high-intensity exercise can reduce or reverse the loss in heart function caused by type 2 diabetes. The study found that three months of high-intensity interval training (HIIT) improved heart function in adults with type 2 diabetes, without any change in medications or diet.” Click here for full story.
Health Paradox: New Diabetes Cases Fall While Obesity Rises
The Washington Post: “The number of new diabetes cases among U.S. adults keeps falling, even as obesity rates climb, and health officials aren’t sure why. New federal data released Tuesday found the number of new diabetes diagnoses fell to about 1.3 million in 2017, down from 1.7 million in 2009.” Click here for full story.
Behavioral Therapy, Exercise Improves Depression in Type 2 Diabetes
Healio: “A combination of cognitive behavioral therapy and consistent exercise can be used to effectively treat major depressive disorder and depressive symptoms in those with type 2 diabetes, even in rural and underserved areas, according to findings published in Diabetes Care.” Click here for full story.
Providers, Regulators Explore Type 2 Therapies for Type 1 Diabetes
Healio: “For most children and adults with type 1 diabetes, day-to-day disease management remains difficult despite improvements in insulin formulations and delivery and advancements in diabetes technologies during the past decade.” Click here for full story.
A Potential Game Changer for Pets with Diabetes
TuftsNow: “When Olaf, a four-year-old Siberian husky, was diagnosed with diabetes in February, there wasn’t anything his owners, Gina and Brian Dacey, wouldn’t do to help him. “We’ve had him since he was a few weeks old, and he’s really still just a baby,” Gina Dacey said.” Click here for full story.
New Gene Variations for Type 2 Diabetes Found
WebMD: “It has long been known that lifestyle affects a person’s risk of developing type 2 diabetes. Now, researchers report that they have identified rare variants of four genes that may also play a part.” Click here for full story.
IBM Works on AI to Detect Chronic Diseases Like Parkinson’s, Diabetes
South China Morning Post: “IBM is banking on artificial intelligence (AI) and connected devices to find new ways to help people stay healthy, as the world copes with an ageing population and prevalent chronic diseases.” Click here for full story.
A Sweet Tale: The Son Who Reinvented Sugar to Help Diabetic Dad
The Guardian: “Javier Larragoiti was 18 when his father was diagnosed with diabetes. The teenager had just started a degree in chemical engineering in Mexico City. So he dedicated his studies to a side project: creating an acceptable alternative to help his father and millions of Mexicans like him avoid sugar.” Click here for full story.
Week of May 22, 2019
FDA Approves Aflibercept (Eylea) for Diabetic Retinopathy
Medscape: “The U.S. Food and Drug Administration (FDA) has approved aflibercept (Eylea, Regeneron) injection solution to treat all stages of diabetic retinopathy, the manufacturer has announced.” Click here for full story.
Research Reveals Insulin-Producing Beta Cells May Change Function in Diabetes
Science Daily: “A revolutionary new study using only materials derived from humans has revealed that insulin-producing beta cells can change their function in diabetes — and that this change may be reversible.” Click here for full story.
“Smart” Insulin Could Help Prevent Complications of Diabetes Treatment
Technology Networks: “UCLA bioengineers and their colleagues have developed a new type of insulin that could help prevent hypoglycemia in people who use the drug to manage diabetes… The treatment is being evaluated for potential clinical trials and, if successful, could change diabetes care. The study was published in the Proceedings of the National Academy of Sciences.” Click here for full story.
Type 1 Diabetes: New Pancreatic Cell Transplant System Shows Promise
Medical News Today: “Scientists have developed a way to increase the effectiveness of pancreatic islet transplantation, a promising therapy for type 1 diabetes. New findings could make pancreatic islet cell transplants more effective.
Immune rejection by the recipient is a major barrier to pancreatic islet transplants from donors becoming routinely available for the treatment of type 1 diabetes.” Click here for full story.
A Diabetes Patient Hurt By a Do-It-Yourself Pancreas Prompts an FDA Warning
LA Times: “The U.S. Food and Drug Administration warned diabetics against building their own artificial pancreas system to help control blood sugar levels after a patient using one suffered an accidental insulin overdose.” Click here for full story.
Few High-Risk Patients Attend Diabetes Prevention Programs
MedPage Today: “Among U.S. adults at high risk for type 2 diabetes, participation in prevention programs was “exceedingly low,” according to authors of a large, population-based survey study… Additionally, healthcare professionals commonly failed to refer high-risk individuals to such programs or to advise lifestyle modifications to prevent diabetes, researchers led by Mohammed Ali, MD, of the CDC’s National Center for Chronic Disease Prevention and Health Promotion in Atlanta, reported online in JAMA Network Open.” Click here for full story.